Finland
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 303.42 M
|
Dec. 31, 2023 | USD 45.55 | -0.27% |
|
Finland |
|
2 |
USD 29.08 M
|
Dec. 31, 2023 | USD 26.42 | 0.60% |
|
Finland |
|
3 |
USD 2.01 M
|
Dec. 31, 2023 | USD 3.51 | -13.37% |
|
Finland |
|
4 |
USD 170.38 K
|
Dec. 31, 2023 | USD 1.68 | 1.85% |
|
Finland |
|
5 |
USD -1.32 M
|
Dec. 31, 2023 | USD 8.76 | -1.71% |
|
Finland |
|
6 |
USD -4.39 M
|
Dec. 31, 2023 | USD 4.48 | 0.37% |
|
Finland |
|
7 |
USD -12.57 M
|
Dec. 31, 2023 | USD 3.59 | 3.74% |
|
Finland |
|
8 |
USD -24.81 M
|
Dec. 31, 2023 | USD 1.33 | 4.66% |
|
Finland |
|
9 |
USD -31.53 M
|
Dec. 31, 2023 | USD 2.50 | 2.59% |
|
Finland |
The Pharmaceuticals company in Finland with the highest Operating Income is Orion Oyj (Helsinki Stock Exchange: ORNBV.HE) at USD 303.42 M.
The Pharmaceuticals company in Finland with the lowest Operating Income is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -31.53 M.
The top 10 Pharmaceuticals companies in Finland by Operating Income are Orion Oyj, Revenio Group Oyj, Biohit Oyj, Herantis Pharma Oyj, Nexstim Plc, Optomed Oyj, Nordhealth AS, Nanoform Finland Oyj and Faron Pharmaceuticals Oy.
The bottom 10 Pharmaceuticals companies in Finland by Operating Income are Faron Pharmaceuticals Oy, Nanoform Finland Oyj, Nordhealth AS, Optomed Oyj, Nexstim Plc, Herantis Pharma Oyj, Biohit Oyj, Revenio Group Oyj and Orion Oyj.